Dasatinib-induced hypoglycemia in a patient with acute lymphoblastic leukemia.
Michelle D LundholmGerald A CharnogurskyPublished in: Clinical case reports (2020)
Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly.
Keyphrases
- acute lymphoblastic leukemia
- type diabetes
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- glycemic control
- case report
- diabetic rats
- adipose tissue
- allogeneic hematopoietic stem cell transplantation
- metabolic syndrome
- oxidative stress
- endothelial cells
- insulin resistance